nifedipine and evans blue
nifedipine has been researched along with evans blue in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fukui, M; Ikezaki, K; Matsukado, K; Nomura, T | 1 |
| Bültmann, R; Starke, K | 1 |
| Oztaş, B | 1 |
| Kwan, CY; Shen, JZ; Zheng, XF | 1 |
| Jodal, M; Lundgren, O; Sörensson, J | 1 |
| Nukhet Turkel, A; Ziya Ziylan, Y | 1 |
| Ding, Z; Hou, XH; Lin, R; Liu, J | 1 |
Other Studies
8 other study(ies) available for nifedipine and evans blue
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Selective increase in blood-tumor barrier permeability by calcium antagonists in transplanted rat brain tumors.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Calcium Channel Blockers; Cell Line; Cerebral Cortex; Dose-Response Relationship, Drug; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Glioma; Infusions, Intra-Arterial; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Nifedipine; Rats; Rats, Wistar | 1994 |
Evans blue blocks P2X-purinoceptors in rat vas deferens.
Topics: Adenosine Triphosphate; Animals; Evans Blue; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Norepinephrine; Potassium; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Suramin; Vas Deferens | 1993 |
The influence of nifedipine on blood-brain barrier permeability during bicuculline-induced seizures.
Topics: Animals; Bicuculline; Blood Pressure; Blood-Brain Barrier; Calcium Channel Blockers; Capillaries; Convulsants; Endothelium, Vascular; Evans Blue; Male; Nifedipine; Pinocytosis; Rats; Rats, Wistar; Status Epilepticus | 1999 |
Evidence for P(2)-purinoceptors contribution in H(2)O(2)-induced contraction of rat aorta in the absence of endothelium.
Topics: Adenosine Triphosphate; Alkaloids; Analysis of Variance; Animals; Aorta; Apyrase; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Catalase; Dantrolene; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Evans Blue; Hydrogen Peroxide; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nickel; Nifedipine; Procaine; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Signal Transduction; Superoxide Dismutase; Suramin; Triazines; Vasoconstrictor Agents | 2000 |
Involvement of nerves and calcium channels in the intestinal response to Clostridium difficile toxin A: an experimental study in rats in vivo.
Topics: Animals; Bacterial Toxins; Calcium Channel Blockers; Calcium Channels; Clostridioides difficile; Coloring Agents; Erythrocyte Volume; Evans Blue; Granisetron; Hexamethonium; Intestine, Small; Male; Nicotinic Antagonists; Nifedipine; Peroxidase; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Statistics, Nonparametric | 2001 |
Protection of blood-brain barrier breakdown by nifedipine in adrenaline-induced acute hypertension.
Topics: Albumins; Animals; Blood Pressure; Blood-Brain Barrier; Calcium Channel Blockers; Capillary Permeability; Drug Administration Schedule; Drug Interactions; Epinephrine; Evans Blue; Hypertension; Male; Nifedipine; Protective Agents; Rats; Rats, Wistar; Vascular Resistance | 2004 |
Experimental pancreatitis results in increased blood-brain barrier permeability in rats: a potential role of MCP-1.
Topics: Acute Disease; Animals; Blood-Brain Barrier; Calcium Channel Blockers; Chemokine CCL2; Evans Blue; Male; Membrane Proteins; Nifedipine; Occludin; Pancreatitis; Permeability; Rats; Rats, Wistar; Severity of Illness Index; Sodium Cholate; Up-Regulation | 2012 |